- CFO Spotlights
- Profiles
- Josiah Craver
Profile
Josiah Craver
Senior Vice President of Finance ( Principal Financial and Accounting Officer), Faeth Therapeutics, Inc.
A later filing names a successor. First published here October 28, 2026; built from records as of October 28, 2026.
Josiah Craver signed the annual report of Faeth Therapeutics, Inc. on Form 10-K as Senior Vice President of Finance ( Principal Financial and Accounting Officer), filed March 30, 2026.1 A later filing by Faeth Therapeutics, Inc., made on June 15, 2026, names Brian Stephenson as its chief financial officer; the record holds no filing that reports the end of Josiah Craver's tenure.
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Faeth Therapeutics, Inc. (SNSE) Pharmaceutical Preparations | Senior Vice President of Finance ( Principal Financial and Accounting Officer) | A later filing names a successor Brian Stephenson, filed June 15, 2026 (filing) |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- March 30, 202610-K filed
Josiah Craver signed the annual report of Faeth Therapeutics, Inc. on Form 10-K as Senior Vice President of Finance ( Principal Financial and Accounting Officer), filed March 30, 2026.
/s/ Josiah Craver Senior Vice President of Finance ( Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by Faeth Therapeutics, Inc., filed with the SEC on March 30, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, Faeth Therapeutics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed March 30, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Josiah Craver wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.